Comments
Lupin has received approval for its propranolol hydrochloride extended-release (ER) capsules, 60 mg, 80 mg, 120 mg and 160 mg from Health Canada. Lupin is the first generic company to receive an approval for generic Inderal-LA capsules for the Canadian market and the product has been approved and will be manufactured from Lupin’s Pithampur Unit-2 facility. The medicine is for the treatment of hypertension and for the prophylaxis of angina pectoris. Shares of Lupin closed 0.64 per cent higher at ₹764 on the BSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.